Drugs / GS-9191
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00499967 | Aug 2007 → Feb 2009 | anogenital human papillomavirus infection | Gilead Sciences | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GS-9191 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00499967 ↗ |
| Modality | Small molecule | — CHEMBL1652465 ↗ |
| Route | Topical | “GS-9191 ointment is intended for topical application directly to genital warts on the skin.” NCT00499967 ↗ |